Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol added to fluticasone versus fluticasone alone in persistent asthma
2012-004854-27Phase 3Completed
- Sponsor
- Novartis
- Start
- May 2015
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in persistent asthma comparing Foradil + Flutide with Flutide alone (2 arms). Primary endpoint: Composite serious asthma-related events. Started May 2015; status: completed.
02
Drugs
formoterolFlixocort
03
Conditions
persistent asthma
Beyond the preview
Go deeper on 2012-004854-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004854-27.